|
⚲
|
| Keyboard |
| Tomsicek Michael John
✚
|
|
|---|---|
| CIK # | 0001570392 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001570392] | |
| 4 | [0001570392] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Acrivon Therapeutics Inc | |
| Tomsicek Michael John | |
| Milestone Pharmaceuticals Inc | |
| CRISPR Therapeutics AG | |
| Abiomed Inc | |
| Cubist Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2025-06-13 | Grant | 20,275 | $0.00 | |
|
Milestone Pharmaceuticals Inc MIST
Stock Option (right to buy) · derivative
|
2025-06-10 | Grant | 40,000 | $0.00 | |
|
Milestone Pharmaceuticals Inc MIST
Stock Option (right to buy) · derivative
|
2024-08-28 | Grant | 40,000 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2024-06-20 | Grant | 20,275 | $0.00 | |
|
Milestone Pharmaceuticals Inc MIST
Stock Option (right to buy) · derivative
|
2023-06-07 | Grant | 30,000 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2022-11-14 | Grant | 35,235 | $0.00 | |
|
Milestone Pharmaceuticals Inc MIST
Common Shares
|
2022-10-19 | Buy | 15,000 | $5.32 | 79,800 |
|
Milestone Pharmaceuticals Inc MIST
Stock Option (right to buy) · derivative
|
2022-07-05 | Grant | 30,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2021-08-06 | Sell | 19,011 | $138.22 | 2,627,700 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2021-08-06 | Sell | 5,989 | $139.46 | 835,226 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2021-08-06 | Option exercise | 25,000 | $17.75 | 443,750 |
|
Milestone Pharmaceuticals Inc MIST
Stock Option (right to buy) · derivative
|
2021-06-14 | Grant | 30,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2021-03-11 | Option exercise | 25,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2021-03-11 | Grant | 9,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2021-03-11 | Grant | 25,360 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2021-03-10 | Tax withheld | 1,352 | $124.15 | 167,851 |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2021-03-10 | Option exercise | 2,833 | ||
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2020-10-05 | Grant | 11,666 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2020-09-01 | Option exercise | 12,000 | $17.75 | 213,000 |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2020-09-01 | Option exercise | 12,000 | $0.00 | |
| showing 20 of 96 most recent transactions | |||||